Major drugmakers were trading sharply lower on Tuesday as Wall Street is bracing for a broader set of tariffs that President ...

Learn more about whether Corcept Therapeutics Incorporated or Novartis AG is a better investment based on AAII's A+ Investor ...

BioReference Health, a biotech company, is laying off 81 employees at its main laboratory in Elmwood Park. The move comes ...

Privately-held German radiopharmaceutical company Isotope Technologies Munich (ITM) has announced the appointment of Celine ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

A new drug may help protect millions of people from heart attacks and strokes by lowering a little-known risk factor in the ...

The drug discovery company, which has partnerships with Eli Lilly and Novartis, is developing AI models to design drugs and ...

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...

Karen Hale, who joined Novartis in 2021 as chief legal officer, will take on the new chief legal and compliance officer role.

Die Deutsche Bank hat die Manager Klaus Moosmayer von Novartis und Kirsty Roth von Thomson Reuters für ihren Aufsichtsrat vorgeschlagen.

AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...

Deutsche Bank AG proposed Novartis AG’s Klaus Moosmayer and Thomson Reuters Corp.’s Kirsty Roth to its supervisory board, replacing two directors with similar areas of expertise in legal matters and ...